May 20, 2022, 5:30 p.m. EDT

CSE Bulletin: Consolidation - Lexston Life Sciences Corp. (LEXT)

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

May 20, 2022 (Newsfile Corp via COMTEX) -- Toronto, Ontario--(Newsfile Corp. - le 20 mai/May 2022) - Lexston Life Sciences Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 11,746,727 common shares.

The name and symbol will not change.

Please note that all open orders will be cancelled at the close of business on May 25, 2022. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

Lexston Life Sciences Corp. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour cinq (5) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 11 746 727 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que tous les ordres ouverts seront annulés à la fermeture des bureaux le 25 mai 2022. Il est rappelé aux concessionnaires de saisir à nouveau leurs ordres en tenant compte du regroupement d'actions.

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à: Listings@thecse.com

COMTEX_407517337/2523/2022-05-20T17:30:10

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

copyright (c) newsfile corp. 2022. all rights reserved

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.